Advertisement MiCardia names new CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

MiCardia names new CEO

MiCardia has announced that Paul Molloy has joined the company as CEO, and has been appointed to the company's board of directors.

Mr Molloy has 20 years of medical device experience in large corporations and venture funded businesses at the senior management level. He began his career as a certified registered nurse anesthetist practicing in The Netherlands before joining Datascope in 1989, where he managed the international cardiac assist business. He has progressed through senior management positions at Baxter (now Edwards), US Surgical (now part of Covideon) and Radiance Medical Systems and Endologix.

Michael Henson, chairman and co-founder of MiCardia, said: “Paul has experience in building technical and commercial organizations, managing medical technology products through the IDE/PMA process and working with investors to finance growth. All of these are skills that will enable MiCardia to move our products through the regulatory process to commercialization.”